PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Dermatology, University of Ottawa, Ottawa, ON, Canada.\', \'Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, BC, Canada.\', \'BC Children\'s Hospital Research Institute, Vancouver, BC, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ijd.15028
?:doi
?:hasPublicationType
?:journal
  • International journal of dermatology
is ?:pmid of
?:pmid
?:pmid
  • 32621284
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.61
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all